Regulator of G Protein Signaling Protein 12 (Rgs12) Controls Mouse Osteoblast Differentiation via Calcium Channel/Oscillation and Gαi-ERK Signaling

Abstract

Bone homeostasis intimately relies on the balance between osteoblasts (OBs) and osteoclasts (OCs). Our previous studies have revealed that regulator of G protein signaling protein 12 (Rgs12), the largest protein in the Rgs super family, is essential for osteoclastogenesis from hematopoietic cells and OC precursors. However, how Rgs12 regulates OB differentiation and function is still unknown. To understand that, we generated an OB‐targeted Rgs12 conditional knockout (CKO) mice model by crossing Rgs12fl/fl mice with Osterix (Osx)‐Cre transgenic mice. We found that Rgs12 was highly expressed in both OB precursor cells (OPCs) and OBs of wild‐type (WT) mice, and gradually increased during OB differentiation, whereas Rgs12‐CKO mice (OsxCre/+; Rgs12fl/fl) exhibited a dramatic decrease in both trabecular and cortical bone mass, with reduced numbers of OBs and increased apoptotic cell population. Loss of Rgs12 in OPCs in vitro significantly inhibited OB differentiation and the expression of OB marker genes, resulting in suppression of OB maturation and mineralization. Further mechanism study showed that deletion of Rgs12 in OPCs significantly inhibited guanosine triphosphatase (GTPase) activity and cyclic adenosine monophosphate (cAMP) level, and impaired Calcium (Ca2+) oscillations via restraints of major Ca2+ entry sources (extracellular Ca2+ influx and intracellular Ca2+ release from endoplasmic reticulum), partially contributed by the blockage of L‐type Ca2+ channel mediated Ca2+ influx. Downstream mediator extracellular signal‐related protein kinase (ERK) was found inactive in OBs of OsxCre/+; Rgs12fl/fl mice and in OPCs after Rgs12 deletion, whereas application of pertussis toxin (PTX) or overexpression of Rgs12 could rescue the defective OB differentiation via restoration of ERK phosphorylation. Our findings reveal that Rgs12 is an important regulator during osteogenesis and highlight Rgs12 as a potential therapeutic target for bone disorders. © 2018 American Society for Bone and Mineral Research.

Association between bile acid metabolism and bone mineral density in postmenopausal women

“…We found that serum total bile acid and FGF19 levels were positively associated with the BMD of the lumbar spine and hip. Zhenxi Li et al have found that the administration of SH-479, which is a bile acid receptor agonist, to mice with postmenopausal osteoporosis increases BMD and improves bone microstructure (8). Moreover, the use of bile acid was found to be an effective treatment for type 2 diabetes, hyperlipidemia, obesity, and other diseases.…”

“…Moreover, it transduces signals mainly by activating the nuclear receptor, farnesoid X receptor (FXR), membrane receptor, and G protein-coupled bile acid receptor 5 (TGR5) (7). A previous study has revealed the occurrence of rapid and severe bone loss after ovariectomy in FXR knockout mice (8). FXR gene knockout has bidirectional effects on the bones.…”

The emerging role of IMD 0354 on bone homeostasis by suppressing osteoclastogenesis and bone resorption, but without affecting bone formation

“…*P < 0.05, **P < 0.01, ***P < 0.005, compared with the controls cellular signaling pathways, such as activation of Smad1/ 5/8 phosphorylation or β-catenin signaling, which can promote osteogenesis 39 . In addition, the activation of ERK is critical for osteoblast differentiation and survival 40,41 . However, the phosphorylation of ERK was shown to be suppressed in osteoblasts similarly to osteoclasts.…”

A direct link betweenPrss53, hair curvature, and skeletal dysplasia

“…In addition, both extracellular calcium and 1,25(OH) 2 D raise the level of intracellular free calcium as a necessary step toward stimulating keratinocyte differentiation 15 . Accumulating studies have shown that calcium oscillations via restraints of major Ca 2+ entry sources (extracellular Ca 2+ influx and intracellular Ca 2+ release from the endoplasmic reticulum) is required for osteoblast differentiation 31 .…”